Ankle bracing practices in ambulatory, corticosteroid-naive boys with Duchenne muscular dystrophy.


Journal

Muscle & nerve
ISSN: 1097-4598
Titre abrégé: Muscle Nerve
Pays: United States
ID NLM: 7803146

Informations de publication

Date de publication:
01 2020
Historique:
received: 16 01 2019
revised: 19 09 2019
accepted: 21 09 2019
pubmed: 8 10 2019
medline: 31 3 2020
entrez: 8 10 2019
Statut: ppublish

Résumé

Loss of ambulation in Duchenne muscular dystrophy presages scoliosis, respiratory failure, and death. Strategies to maintain ankle range of motion are employed, but little evidence exists to support these approaches and limited information is available concerning current practice. In this study we assessed baseline bracing data from 187 boys participating in a multicenter, international clinical trial. Ankle-foot orthoses (AFOs) were recommended for 54% of the boys, with nighttime static AFOs and nighttime dynamic AFOs utilized in 94% and 6% of these boys, respectively. Daytime static AFOs were recommended for 3 boys. Compliance with bracing recommendations was 54% for nighttime static braces and 67% for nighttime dynamic braces. The basis for the variation in recommended AFO use is unknown and requires further study. Long-term follow-up of boys may permit assessment of the effects of AFO use.

Identifiants

pubmed: 31588574
doi: 10.1002/mus.26727
doi:

Types de publication

Journal Article Multicenter Study Randomized Controlled Trial Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

52-57

Subventions

Organisme : NINDS NIH HHS
ID : U01 NS061795
Pays : United States
Organisme : NINDS NIH HHS
ID : U01 NS061799
Pays : United States

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Références

Kinali M, Main M, Eliahoo J, et al. Predictive factors for the development of scoliosis in Duchenne muscular dystrophy. Eur J Paediatr Neurol. 2007;11:160-166.
Zanotelli E. Predicting the loss of ambulation in Duchenne muscular dystrophy. Arq Neuropsiquiatr. 2014;72:1-2.
Sutherland DH, Olsen R, Cooper L, et al. The pathomechanics of gait in Duchenne muscular dystrophy. Dev Med Child Neurol. 1981;23:3-22.
Birnkrant D, Bushby K, Bann CM, et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management. Lancet Neurol. 2018;17:251-267.
Bushby K, Finkel R, Birnkrant DJ, et al. Diagnosis and management of Duchenne muscular dystrophy, part 2: Implementation of multidisciplinary care. Lancet Neurol. 2010;9:177-189.
Guglieri M, Bushby K, McDermott MP, et al. Developing standardized corticosteroid treatment for Duchenne muscular dystrophy. Contemp Clin Trials. 2017;58:34-39.
Mayhew AG, Cano SJ, Scott E, et al. and the North Star Clinical Network for Neuromuscular Disease. Detecting meaningful change using the North Star Ambulatory Assessment in Duchenne muscular dystrophy. Dev Med Child Neurol. 2013;55:1046-1052.
McDonald CM, Henricson EK, Abresch RT, et al. The 6-minute walk test and other endpoints in Duchenne muscular dystrophy: longitudinal natural history observations over 48 weeks from a multicenter study. Muscle Nerve. 2013;48:343-356.
Soucie JM, Wang C, Forsyth A, et al. Range of motion measurements: reference values and a database for comparison studies. Haemophilia. 2011;17:500-507.
Jansen M, de Groot LJ, van Alfen N, Geurts A. Physical training in boys with Duchenne muscular dystrophy: the protocol of the No Use is Disuse study. BMC Pediatr. 2010;10:55.
Case LE, Apkon SD, Eagle M, et al. Rehabilitation management of the patient with Duchenne muscular dystrophy. Pediatrics. 2018;142(suppl 2):S17-S33.
Glanzman AM, Flickinger JM, Dholakia KH, Bonnemann CG, Finkel RS. Serial casting for the management of ankle contracture in Duchenne muscular dystrophy. Pediatr Phys Ther. 2011;23:275-279.
Imbens GW, Rubin DB. Causal Inference for Statistics, Social, and Biomedical Sciences: An Introduction. New York, NY: Cambridge University Press; 2015.

Auteurs

Victoria Kern (V)

Rehabilitative Medicine, Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania.

Matthew Wicklund (M)

Department of Neurology, University of Colorado School of Medicine, Aurora, Colorado.

Anne Haulman (A)

Department of Neurology, Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania.

Michael P McDermott (MP)

Department of Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester, New York.
Department of Neurology, University of Rochester Medical Center, Rochester, New York.

William B Martens (WB)

Department of Neurology, University of Rochester Medical Center, Rochester, New York.

Robert C Griggs (RC)

Department of Neurology, University of Rochester Medical Center, Rochester, New York.

Ashutosh Kumar (A)

Division of Pediatric Neurology, Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH